• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

噬菌体概念与应用:噬菌体治疗综述

Bacteriophages Concept and Applications: A Review on Phage Therapy.

机构信息

Department of Pharmaceutical Sciences and Natural Products, Central University of Punjab, Bathinda, 151401, India.

National Institute of Malaria Research Field Unit Guwahati, 781022 (Assam), India.

出版信息

Curr Pharm Biotechnol. 2023;24(10):1245-1264. doi: 10.2174/1389201024666221104142457.

DOI:10.2174/1389201024666221104142457
PMID:36336808
Abstract

The nature of phages was a matter of dispute, which was resolved in 1940, and it was continued to develop their activity and application in the Soviet Union and Eastern Europe. Bacteriophages were first employed in 1919 to treat bacterial illnesses caused by Citrobacter, Enterobacter, and . Bacteriophages range in complexity from simple spherical viruses with genome sizes of less than 5 kbp to complicated viruses with genome sizes surpassing 280 kbp. They have two significant parts, head and tail, and are made up of numerous copies of more than 40 distinct proteins. Bacteriophages have been demonstrated to bind with receptors in the walls of both gram-positive and gram-negative bacteria, ranging from peptide sequences to polysaccharide moieties. Depending on the type of phage and the physiological state of the bacterium, the life cycle may diverge into the lytic cycle or lysogenic cycle. Lytic-lysogenic switch depends on a variety of inducing factors. Bacteriophage therapy can be administered via several routes, but parenteral routes are the most effective. Auto-dosing, single-dose potential, lack of cross-resistance with antibiotics, etc., are several advantages of phage therapy over antibiotic treatment. Bacteriophages are attracting much attention because of their potential advantages and wide applications as antibacterial agents, diagnostic technologies, phage-based products, and biocontrol agents. They also have several applications in the food industry, agriculture/crop, farm animal and bee protection, environmental, and biosensor development.

摘要

噬菌体的性质曾存在争议,这一争议在 1940 年得以解决,此后,噬菌体在苏联和东欧的活性和应用得到了持续发展。噬菌体于 1919 年首次被用于治疗由柠檬酸杆菌、肠杆菌属和其他细菌引起的细菌感染。噬菌体的复杂程度从基因组大小小于 5 kbp 的简单球形病毒到基因组大小超过 280 kbp 的复杂病毒不等。它们有两个重要部分,头部和尾部,由许多不同的蛋白质组成,数量超过 40 个。噬菌体已被证明可以与革兰氏阳性和革兰氏阴性细菌的细胞壁上的受体结合,其结合受体的种类从肽序列到多糖部分都有。根据噬菌体的类型和细菌的生理状态,生命周期可能会分为裂解周期或溶原周期。裂解-溶原开关取决于多种诱导因素。噬菌体治疗可以通过多种途径进行,但肠外途径是最有效的。与抗生素治疗相比,噬菌体治疗具有自动给药、单次剂量潜力、与抗生素无交叉耐药性等优势。噬菌体作为抗菌剂、诊断技术、基于噬菌体的产品和生物防治剂具有潜在的优势和广泛的应用,因此引起了人们的极大关注。它们在食品工业、农业/作物、农场动物和蜜蜂保护、环境和生物传感器开发等领域也有多种应用。

相似文献

1
Bacteriophages Concept and Applications: A Review on Phage Therapy.噬菌体概念与应用:噬菌体治疗综述
Curr Pharm Biotechnol. 2023;24(10):1245-1264. doi: 10.2174/1389201024666221104142457.
2
Bacteriophages: an overview of the control strategies against multiple bacterial infections in different fields.噬菌体:不同领域中针对多种细菌感染的控制策略概述。
J Basic Microbiol. 2019 Feb;59(2):123-133. doi: 10.1002/jobm.201800412. Epub 2018 Nov 28.
3
Bacteriophages: from Isolation to Application.噬菌体:从分离到应用。
Curr Pharm Biotechnol. 2022;23(3):337-360. doi: 10.2174/1389201022666210426092002.
4
Complete genome sequences of Aeromonas and Pseudomonas phages as a supportive tool for development of antibacterial treatment in aquaculture.完整的气单胞菌和假单胞菌噬菌体基因组序列可作为水产养殖中抗菌治疗开发的辅助工具。
Virol J. 2019 Jan 8;16(1):4. doi: 10.1186/s12985-018-1113-5.
5
Characterization of four virulent Klebsiella pneumoniae bacteriophages, and evaluation of their potential use in complex phage preparation.鉴定四种毒力较强的肺炎克雷伯氏菌噬菌体,并评估其在复杂噬菌体制剂中的潜在应用。
Virol J. 2021 Jan 6;18(1):9. doi: 10.1186/s12985-020-01485-w.
6
Diversity of phage infection types and associated terminology: the problem with 'Lytic or lysogenic'.噬菌体感染类型的多样性及相关术语:“裂解或溶原”的问题
FEMS Microbiol Lett. 2016 Apr;363(7). doi: 10.1093/femsle/fnw047. Epub 2016 Feb 29.
7
Bacteriophage genome engineering for phage therapy to combat bacterial antimicrobial resistance as an alternative to antibiotics.噬菌体基因组工程在噬菌体治疗中的应用,以对抗细菌对抗生素的耐药性,作为抗生素的替代品。
Mol Biol Rep. 2023 Aug;50(8):7055-7067. doi: 10.1007/s11033-023-08557-4. Epub 2023 Jul 1.
8
Phage Therapy for Crops: Concepts, Experimental and Bioinformatics Approaches to Direct Its Application.噬菌体治疗作物:直接应用的概念、实验和生物信息学方法。
Int J Mol Sci. 2022 Dec 25;24(1):325. doi: 10.3390/ijms24010325.
9
Associations among Antibiotic and Phage Resistance Phenotypes in Natural and Clinical Isolates.天然和临床分离株中抗生素和噬菌体耐药表型的相关性。
mBio. 2017 Oct 31;8(5):e01341-17. doi: 10.1128/mBio.01341-17.
10
Repeated outbreaks drive the evolution of bacteriophage communication.噬菌体的反复爆发驱动了其通讯方式的进化。
Elife. 2021 Jan 18;10:e58410. doi: 10.7554/eLife.58410.

引用本文的文献

1
Characterization and genomics of phage Henu2_3 against K1 Klebsiella pneumoniae and its efficacy in animal models.抗K1型肺炎克雷伯菌噬菌体Henu2_3的特性、基因组学及其在动物模型中的疗效
AMB Express. 2025 Jul 30;15(1):112. doi: 10.1186/s13568-025-01919-0.
2
Combating Antibiotic Resistance: Mechanisms, Multidrug-Resistant Pathogens, and Novel Therapeutic Approaches: An Updated Review.对抗抗生素耐药性:机制、多重耐药病原体及新型治疗方法:最新综述
Pharmaceuticals (Basel). 2025 Mar 12;18(3):402. doi: 10.3390/ph18030402.
3
Phagetherapy updates: New frontiers against antibiotic resistance.
吞噬疗法的进展:对抗抗生素耐药性的新前沿。
Eur J Microbiol Immunol (Bp). 2025 Mar 17;15(1):1-12. doi: 10.1556/1886.2024.00126. Print 2025 Mar 19.
4
Enhanced bacteriostatic effects of phage vB_C4 and cell wall-targeting antibiotic combinations against drug-resistant .噬菌体vB_C4与细胞壁靶向抗生素联合使用对耐药菌的抑菌作用增强。
Microbiol Spectr. 2025 Feb 4;13(2):e0190824. doi: 10.1128/spectrum.01908-24. Epub 2025 Jan 16.
5
Bacteriophage Therapy as a Promising Alternative for Antibiotic-Resistant : Advances and Challenges.噬菌体疗法作为抗生素耐药性的一种有前景的替代方法:进展与挑战
Antibiotics (Basel). 2024 Nov 23;13(12):1120. doi: 10.3390/antibiotics13121120.
6
An Edible Antibacterial Coating Integrating Lytic Bacteriophage Particles for the Potential Biocontrol of in Ripened Cheese.一种整合裂解性噬菌体颗粒的可食用抗菌涂层,用于对成熟奶酪中[具体微生物]的潜在生物防治 。 (注:原文中“in Ripened Cheese”前缺少具体针对的微生物名称)
Polymers (Basel). 2024 Mar 2;16(5):680. doi: 10.3390/polym16050680.
7
Mucin and Agitation Shape Predation of by Lytic Coliphage.黏液和搅动影响裂解性大肠杆菌噬菌体的捕食作用
Microorganisms. 2023 Feb 17;11(2):508. doi: 10.3390/microorganisms11020508.